Trilogy Metals Inc.
TMQ NYSE Gold And Silver Ores Financials FY2016โFY2025
Last close ยท Oct 23, 2026
$2.06
3.3%What Trilogy Metals Inc. does
No business description yet.
- Legal name
- Trilogy Metals Inc.
- Fiscal year ends
- November 30, 2025
- Latest annual report
- 10-K ยท Feb 17, 2026
- Accession ยท CIK
- 0001104659-26-015668
0001543418
Revenue and margins
Trilogy Metals Inc. had โ of revenue in fiscal 2025.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was โ in fiscal 2025, โ of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Trilogy Metals Inc. returned โ to shareholders in fiscal 2025. The diluted share count rose 3.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Trilogy Metals Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $6.3M | $2.6M | $2.6M | $25.8M | $51.6M |
| Current ratio | 6.4x | 5.4x | 6.2x | 32.8x | 1.6x |
| Quick ratio | 6.4x | 5.4x | 6.2x | 32.8x | 1.6x |
| Total assets | $167M | $146M | $138M | $134M | $157M |
| Total liabilities | $1.3M | $0.6M | $0.5M | $0.9M | $33.2M |
| Shareholders' equity | $166M | $145M | $138M | $133M | $124M |
| Net debt (โ = net cash) | โ | โ | โ | โ | โ |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. โPlanโ marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
โ
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8โ9 is strong, 0โ2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations is positive | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Return on assets rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations exceeds net income | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Debt fell relative to assets | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Current ratio rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Share count didn't rise | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Gross margin rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Revenue rose relative to assets | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| F-score | โ / 3 | 2 / 7 | 3 / 7 | 2 / 7 | โ / 6 | โ / 6 | โ / 6 | โ / 6 | โ / 6 | โ / 6 |
| Accruals ratio | 8.2% | โ13.1% | 0.5% | โ8.3% | 143.5% | โ9.4% | โ13.0% | โ8.4% | โ5.0% | โ26.8% |
| Altman Z'' | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
10 years of figures
Amounts in USD. Hover a ratioโs name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $0.1M | $0.1M | $0.3M | $0.5M | โ | โ | โ | โ | โ | โ |
| Net interest income | $0.1M | $0.1M | $0.3M | $0.5M | โ | โ | โ | โ | โ | โ |
| Research and development | โ | โ | โ | โ | $1.1M | โ | โ | โ | โ | โ |
| Income tax | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Net income | โ$4.9M | โ$21.1M | โ$21.8M | โ$27.9M | $162M | โ$21.7M | โ$24.3M | โ$15.0M | โ$8.6M | โ$42.2M |
| Diluted EPS | $0.05 | $0.20 | โ$0.18 | โ$0.21 | $1.12 | โ$0.15 | โ$0.17 | โ$0.10 | โ$0.05 | โ$0.26 |
| Diluted shares | 0.11B | 0.11B | 0.12B | 0.14B | 0.14B | 0.14B | 0.15B | 0.15B | 0.16B | 0.16B |
| Cash flow | ||||||||||
| Cash from operations | โ$8.7M | โ$15.4M | โ$22.1M | โ$23.5M | โ$8.3M | โ$5.1M | โ$3.9M | โ$3.1M | โ$1.8M | โ$3.2M |
| Capital expenditure | $0.1M | $0.3M | $0.0M | $0.6M | โ | โ | โ | โ | โ | โ |
| Free cash flow | โ$8.8M | โ$15.7M | โ$22.1M | โ$24.1M | โ | โ | โ | โ | โ | โ |
| Depreciation and amortization | $0.1M | $0.1M | $0.2M | $0.2M | $0.1M | $0.0M | $0.0M | $0.0M | $0.0M | โ |
| Stock-based compensation | $0.6M | โ$0.7M | โ$1.4M | โ$3.8M | โ$3.6M | โ$3.5M | โ$3.4M | โ$3.8M | โ$3.5M | โ$3.3M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $14.9M | $7.9M | $23.0M | $19.2M | $11.1M | $6.3M | $2.6M | $2.6M | $25.8M | $51.6M |
| Current assets | $15.6M | $9.1M | $23.6M | $20.2M | $11.4M | $6.6M | $2.9M | $2.9M | $26.0M | $51.9M |
| Current liabilities | $0.6M | $4.2M | $1.7M | $2.4M | $1.0M | $1.0M | $0.5M | $0.5M | $0.8M | $33.1M |
| Property and equipment, net | $0.2M | $0.5M | $0.3M | $0.7M | $0.2M | $0.0M | $0.0M | $0.0M | โ | โ |
| Total assets | $46.7M | $40.3M | $54.7M | $51.6M | $185M | $167M | $146M | $138M | $134M | $157M |
| Total liabilities | $0.6M | $14.6M | $22.5M | $33.4M | $1.5M | $1.3M | $0.6M | $0.5M | $0.9M | $33.2M |
| Shareholders' equity | $46.2M | $25.7M | $32.2M | $18.3M | $184M | $166M | $145M | $138M | $133M | $124M |
| Margins | ||||||||||
| Net margin | โ7,970.5% | โ35,769.5% | โ6,314.7% | โ5,581.0% | โ | โ | โ | โ | โ | โ |
| FCF margin | โ14,449.2% | โ26,628.8% | โ6,380.6% | โ4,827.4% | โ | โ | โ | โ | โ | โ |
| Net interest share of revenue | 100.0% | 100.0% | 100.0% | 100.0% | โ | โ | โ | โ | โ | โ |
| Returns | ||||||||||
| Return on equity | โ10.5% | โ58.8% | โ75.5% | โ110.6% | 160.1% | โ12.4% | โ15.6% | โ10.6% | โ6.4% | โ32.9% |
| Return on assets | โ10.4% | โ48.5% | โ46.0% | โ52.5% | 136.6% | โ12.3% | โ15.5% | โ10.5% | โ6.3% | โ29.0% |
| Return on tangible equity | โ10.5% | โ82.2% | โ67.8% | โ152.8% | 88.0% | โ13.0% | โ16.7% | โ10.9% | โ6.5% | โ34.0% |
| Growth | ||||||||||
| Revenue growth | โ | โ3.3% | 486.4% | 44.5% | โ | โ | โ | โ | โ | โ |
| Net income growth | โ | โ | โ | โ | โ | โ113.4% | โ | โ | โ | โ |
| EPS growth | โ | 300.0% | โ190.0% | โ | โ | โ113.4% | โ | โ | โ | โ |
| Share count change | โ | 0.4% | 15.4% | 11.0% | 6.9% | โ0.1% | 0.9% | 4.8% | 4.7% | 3.1% |
| Financial health | ||||||||||
| Current ratio | 26.4x | 2.1x | 14.3x | 8.6x | 10.9x | 6.4x | 5.4x | 6.2x | 32.8x | 1.6x |
| Quick ratio | 26.4x | 2.1x | 14.3x | 8.6x | 10.9x | 6.4x | 5.4x | 6.2x | 32.8x | 1.6x |
| Capital allocation | ||||||||||
| Capex / revenue | 200.0% | 508.5% | 2.0% | 129.0% | โ | โ | โ | โ | โ | โ |
| Stock comp / revenue | 1,008.2% | โ1,194.9% | โ416.5% | โ769.0% | โ | โ | โ | โ | โ | โ |
| Quality scores | ||||||||||
| Piotroski F-score | โ | 2.0 | 3.0 | 2.0 | โ | โ | โ | โ | โ | โ |
| Accruals ratio | 8.2% | โ13.1% | 0.5% | โ8.3% | 143.5% | โ9.4% | โ13.0% | โ8.4% | โ5.0% | โ26.8% |
Source: SEC EDGAR XBRL filings (CIK 0001543418). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only โ not investment advice. Check the original filings before relying on any figure.
